Sawada, K., Kawamoto, Y., Harada, K., Ando, T., Sogabe, S., Kobayashi, Y., Dazai, M., Nakamura, M., Hatanaka, K., Ishiguro, A., Sato, A., Nakano, S., Shindo, Y., Hosokawa, A., Ito, K., Yoshikawa, A., Iuchi, K., Yokota, I., Yuki, S., Komatsu, Y. (2025). Results of a phase 2 trial of ramucirumab plus docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.447